In the crude analysis (Model 0), the odds ratios (OR) for metabolic syndrome was 3.2 (1.6–6.4, p = 0.001) with A-FABP and 2.7 (0.8–8.7, p = 0.1) with chemerin. Here, RARRES2 is linked to metabolic syndrome.